The European region currently differs in many aspects, such as political, socioeconomic, and geographical. After substantial political changes at the beginning of the 1990s, the majority of central and eastern European countries started to rebuild their healthcare systems. It is apparent that eastern Europe represents a highly diverse region where the difference among countries broadens year after year. In highly industrialised countries of Europe, the leading causes of childhood serious visual loss are lesions of the central nervous system, congenital anomalies and retinal disorders. In the middle income countries of Europe, congenital cataract, glaucoma and, mainly, retinopathy of prematurity are highly expressed. The major cause of serious visual loss in adults in industrialised countries is age related macular degeneration. The other conditions comprise cataract, glaucoma, diabetic retinopathy, and uncorrected/uncorrectable refractive errors, along with low vision. In people of working age, diabetic retinopathy, retinopathy pigmentosa, and optic atrophy are the most frequently reported causes of serious visual loss. In the middle income countries of Europe, advanced cataract, glaucoma, and diabetic retinopathy are more frequently observed.

Charles University University Eye Clinic Prague Czech Republic

Zobrazit více v PubMed

European Health for All Series. Health 21: the Health for all policy framework for the WHO European Region; No 6, WHO, Copenhagen. 1999. PubMed

Calvocoressi P. World politics since 1945. 7th ed. New York: Longman Publishing 1997:207–357.

Bash PF. Textbook on international health. 2nd ed. New York: Oxford University Press 1999:370–454.

The World Health Report 2000. Health systems: improving performance. Geneva: WHO, 2000. PubMed

Instituto del Tercer Mundo. The world guide 1999/2000. 1st ed. Oxford: New Internationalis Publications, 1999.

World Bank. Investing in health. World development report. New York: World Bank, 1993.

The World Health Report. Life in the 21st century—a vision for all. Geneva: WHO, 1998:47.

Thylefors B. Some global aspects of blindness. Int Ophthalmol 1982;5:127–36. PubMed

Albert DM, Jakobiec FA. Principles and practice of ophthalmology. 1st ed. Philadelphia: WB Saunders, 1994:782–90, 2799–812.

Thylefors B, Negrel AD, Pararajasegaram R, et al. Available data on blindness. Ophthalmic Epidemiol 1995;2:5–39. PubMed

Thompson JR, Rosenthal AR. Epidemiology of world blindness. Curr Opin Ophthalmol 1990;1:649–53.

Thylefors B. The World Health Organization's programme for the prevention of blindness. Int Ophthalmol 1990;14:211–19. PubMed

Thylefors B. A global initiative for the elimination of avoidable blindness. Am J Ophthalmol 1998;125:90–3. PubMed

World Health Organization. Strategies for the prevention of blindness in national programmes. 2nd ed. Geneva: WHO, 1997.

World Health Organization. International statistical classification of diseases and related health problems. Tenth revision. Vol 1. Geneva: WHO, 1992:457. PubMed

Graham PA, Wallace J, Welsby E, et al. Evaluation of postal detection of registrable blindness. Br J Prev Soc Med 1968;22:238–41. PubMed PMC

Wormald R, Evans J. Registration of blind and partially sighted people. Br J Ophthalmol 1994;78:733–4. PubMed PMC

Robinson R, Deutsch J, Jones HS, et al. Unrecognised and unregistered visual impairment. Br J Ophthalmol 1994;78:736–40. PubMed PMC

Thompson A, Du L, Rosenthal AR. Recent trends in registration of blindness and partial sight in Leicestershire. Br J Ophthalmol 1989;73:88–94. PubMed PMC

Minassian DC. Epidemiological methods in prevention of blindness. Eye 1988;2(Suppl):S3–12. PubMed

Frederick MA, Javitt JC, Chiang YP. Cost effectiveness of the screening and treatment of retinopathy. Int J Technol Assess Health Care 1992;8:694–707. PubMed

Kupfer C. Ophthalmic research: Impact on prevention of blindness. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness, 2001:421–8.

Gilbert C, Foster A, Negrel A, et al. Childhood blindness: a new form for recording causes of visual loss in children. Bull World Health Organ 1993;71:485–9. PubMed PMC

Gilbert C. Childhood blindness. In: Johnson GJ, Minassian DC, Weale R, eds. The epidemiology of eye disease. 1st ed. London: Chapman and Hall 1998:181–208.

Kohler L. Early detection and screening programs for children in Sweden. In: Macfarlane JA, ed. Progress in child health. Vol 1. Edinburgh: Churchill Livingstone 1984:230–2.

Foster A, Gilbert C. Epidemiology of visual impairment in children. In: Taylor D, ed. Paediatric ophthalmology. 2nd ed. Oxford: Blackwell Science, 1997.

Gilbert C, Anderton L, Foster A. Prevalence of blindness in children: a review of available data. Ophthalmic Epidemiol 1999;6:73–82. PubMed

Gilbert C, Rahi J, Eckstein M, et al. Hereditary disease as a cause of childhood blindness: regional variation. Ophthalmol Genet 1995;16:1–10. PubMed

Gilbert CE, Anderton L, Dandona L, et al. Prevalence of visual impairment in children: a review of available data. Ophthalmic Epidemiol 1999;6:73–82. PubMed

Kohler L, Stigmar G. Vision screening of four year old children. Acta Paediatr Scand 1973;62:17–27. PubMed

Phillips CI, Levy AM, Newton M, et al. Blindness in schoolchildren: importance of heredity, congenital cataract, and prematurity. Br J Ophthalmol 1987;71:578–84. PubMed PMC

Stayte M, Johnson A, Wortham C. Ocular and visual defects in a geographically defined population of 2-year-old children. Br J Ophthalmol 1990;74:465–8. PubMed PMC

Stewart-Brown S L, Butler NR. Visual acuity in a national sample of ten year old children. J Epidemiol Community Health 1985;39:107–12. PubMed PMC

Norrie G. Causes of blindness in children. Acta Ophthalmol (Copenh) 1927;5:357–86.

Foster A, Gilbert C E, Rahi J. Epidemiology of cataract in childhood: a global perspective. J Cataract Refract Surg 1997;23(Suppl 1):S601–3. PubMed

Gilbert CE, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middle-income countries. Lancet 1997. :12–14. PubMed

Fledelius HC. Retinopathy of prematurity. Acta Ophthalmol (Copenh) 1990;68:209–13. PubMed

Hansen SE, Rosenberg T, Fledelius HC. Blindness due to retrolental fibroplasis in Denmark 1948–1985. Ugeskr Laeger 1987;149:1839–42. PubMed

Hornby SJ, Gilbert CE, Rahi JK, et al. Regional variation in blindness in children due to microphthalmos, anophthalmos and coloboma. Ophthalmic Epidemiol 2000;7:127–38. PubMed

Rosenberg T. Congenital and hereditary visual impairment in Greenland. Arctic Med Res 1994;53:91–6. PubMed

Stoll C, Alembik Y, Dott B, et al. Epidemiology of congenital eye malformations in 131 760 consecutive births. Ophthalmic Paediatr Genet 1992;13:179–86. PubMed

Robinson GC, Jan JE, Kinnis C. Congenital ocular blindness in children, 1945 to 1984. Am J Dis Child 1987;141:1321–4. PubMed

Laga M, Meheus A, Piot P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull World Health Organ 1989;67:471–8. PubMed PMC

Riise R, Flage T, Hansen E, et al. Visual inpairment in Nordic children. I. Nordic registers and prevalence data. Acta Ophthalmol (Copenh) 1992;70:145–54. PubMed

Rosenberg T, Flage T, Hansen E, et al. Visual impairment in Nordic children. II. Aetiological factors. Acta Ophthalmol (Copenh) 1992;70:155–64. PubMed

Hansen E, Flage T, Rosenberg T, et al. Visual impairment in Nordic children. III. Diagnosis. Acta Ophthalmol (Copenh) 1992;70:597–604. PubMed

Riise R, Flage T, Hansen E, et al. Visual impairment in Nordic children. IV. Sex distribution. Acta Ophthalmol (Copenh) 1992;70:605–9. PubMed

Blohme J, Tornqvist K. Visual impairment in Swedish children. III. Diagnoses. Acta Ophthalmol Scand 1997;75:681–7. PubMed

Lindstedt E. In: Schappert-Kimmijser J, ed. Causes of severe visual impairment in children and their prevention. Doc Ophthalmol 1975;39:287–97. PubMed

Lindstedt E. Severe visual impairment in Swedish children. Doc Ophthalmol 1972;31:173–202. PubMed

Rosenberg T, Flage T, Hansen E, et al. Incidence of registered visual impairment in the Nordic child population. Br J Ophthalmol 1996;80:49–53. PubMed PMC

Rosenberg T. Visual impairment in Danish children. Acta Ophthalmol (Copenh) 1987;65:110–17. PubMed

Halldorsson S, Bjornsson G. Childhood blindness in Iceland. A study of legally blind and partially seeing children in Iceland 1978. Acta Ophthalmol (Copenh) 1980;58:237–42. PubMed

Goggin M, O'Keefe M. Childhood blindness in the Republic of Ireland: a national survey. Br J Ophthalmol 1991;75:425–9. PubMed PMC

Stewart-Brown SL, Haslum MN. Partial sight and blindness in children of the 1970 birth cohort at 10 years of age. J Epidemiol Commun Health 1988;42:17–23. PubMed PMC

Rahi JS, Dezateux C. Epidemiology of visual impairment in Britain. Arch Dis Child 1998;78:381–6. PubMed PMC

Bryas JH, Archer DB. Aetiological survey of visually handicapped children in Northern Ireland. Trans Ophthalmol Soc UK 1997;97:26–30. PubMed

Taylor D. The prevalence of visual handicap in children in England and Wales. Child Care, Health and Development 1975;1:291–7. PubMed

Czeizel A, Torzs E, Diaz LG, et al. An etiological study on 6 to 14 years old children with severe visual handicap in Hungary. Acta Paediatr Hung 1991;31:365–77. PubMed

Kocur I, Kuchynka P, Rodny S, et al. Causes of severe visual impairment and blindness in children attending schools for the visually handicapped in the Czech Republic. Br J Ophthalmol 2001;85:1149–52. PubMed PMC

Gerinec A, Chynoransky M, Smykova T. Causes of blindness and low vision of children in the Slovak Republic. Cs Oftalmologie 1990;2:121–7. PubMed

Rogers NK, Gilbert CE, Foster A, et al. Childhood blindness in Uzbekistan. Eye 1999;13( Pt 1):65–70. PubMed

Evans JR, Wormald RPL. Is the incidence of age-related macular degeneration increasing? Br J Ophthalmol 1996;80:9–14 PubMed PMC

Evans J. Age-related macular degeneration. In: Johnson GJ, Minassian DC, Weale R, eds. The epidemiology of eye disease. 1st ed. London: Chapman and Hall, 1998:325–47.

International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995;39:367–74. PubMed

Bressler NM, Bressler SB. Preventive ophthalmology. Age-related macular degeneration. Ophthalmology 1995;102:1206–11. PubMed

Vingerling JR, Dielemans I, Hofman, A et al. The prevalence of age related maculopathy in the Rotterdam study. Ophthalmology 1995;102:205–10. PubMed

Vingerling JR, Klaver CCW, Hofman A, et al. Epidemiology of age-related maculopathy. Epidemiol Rev 1995;17:347–60. PubMed

Eye Disease Case Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701–8. PubMed

Klein R, Klein BEK, Linton KL. Prevalence of age related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933–43. PubMed

Vinding T. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol 1990;68:162–7. PubMed

Vinding T. Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 1989;67:609–16. PubMed

Foster A, Johnson GJ. Magnitude and causes of blindness in the developing world. Int Ophthalmol 1990;14:135–40. PubMed

Gieser SC, Schein OD. Cataract epidemiology and world blindness. Curr Opin Ophthalmol 1993;4:10–13.

Goldstein H. The reported demography and causes of blindness throughout the world. Adv Ophthalmol 1980;40:1–90. PubMed

Grey RHB, Burns-Cox CJ, Hughes A. Blind and partial sight registration in Avon. Br J Ophthalmol 1989;73:88–94. PubMed PMC

Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996;80:844–8. PubMed PMC

Weale R. Why does the human visual system age in the way it does? Exp Eye Res 1995;60:49–55. PubMed

Wormald RP, Wright LA, Courtney P, et al. Visual problems in the elderly population and the implications for services. BMJ 1992;304:1226–9. PubMed PMC

Abou-Gareeb I, Lewallen S, Basset K, et al. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiology 2001;8:39–56. PubMed

Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653–8. PubMed

Ghafour IM, Allan D, Foulds W. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983;67:209–13. PubMed PMC

Nicolosi A, Marighi PE, Riyyardi P, et al. Prevalence and causes of visual impairment in Italy. Int J Epidemiol 1994;23:359–64. PubMed

Vassileva P, Gieser SC, Vitale S, et al. Blindness and visual impairment in Western Bulgaria. Ophthalmic Epidemiol 1996;3:143–9. PubMed

Doci J, Juhas T, Klisenbauer D, et al. Occurrence of blindness in Slovak Socialistic Republic. Cs Oftalmologie 1988;4:241–6. PubMed

Foster A. Cataract and “Vision 2020—the right to sight' initiative. Br J Ophthalmol 2001;85:635–9. PubMed PMC

Minassian DC, Reidy A, Desai P, et al. The deficit in cataract surgery in England and Wales and the escalating problem of visual impairment: epidemiological modeling of the population dynamics of cataract. Br J Ophthalmol 2000;84:4–8. PubMed PMC

Taylor HR. Cataract: a global public health challenge. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness 2001:37–46

Taylor H. Cataract: how much surgery do we have to do? Br J Ophthalmol 2000;84:1–2. PubMed PMC

Taylor HR. The epidemiology of age related cataract. Eye 1999;13:445–8. PubMed

Gillies M, Brian G, LaNauze J, et al. Modern surgery for global cataract blindness. Arch Ophthalmol 1998;116:90–2. PubMed

Dolin P. Epidemiology of cataract. In: Johnson GJ, Minassian DC, Weale R, eds. The epidemiology of eye disease. 1st ed. London: Chapman and Hall 1998:103–18.

Gieser SC, Vassileva P, West SK. Ophthalmology in Bulgaria. Arch Ophthalmol 1994;112:687–90. PubMed

West SK. Epidemiology of risk factors for age related cataract. Surv Ophthalmol 1995;39:323–34. PubMed

Sarma U, Brunner E, Evans JR, et al. Nutrition and the epidemiology of cataract and age-related maculopathy. Eur J Clin Nutr 1994;48:1–8. PubMed

Italian American Cataract Study Group. Risk factors for age related cortical, nuclear and posterior subcapsular cataracts. Am J Epidemiol 1991;133:541–53. PubMed

Bailey C. Screening for Diabetic Retinopathy. Focus. London: The Royal College of Ophthalmologists, 2001(15).

Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000;78:374–85. PubMed

Klein BEK, Klein R. Diabetic retinopathy. In: Johnson GJ, Minassian DC, Weale R, eds. The epidemiology of eye disease. 1st ed. London: Chapman and Hall 1998:311–24.

Sjolie AK, Stephenson J, Aldington S, et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe: The EURODIAB IDDM complications study. Ophthalmology 1997;104:252–60. PubMed

Trautner C, Plum F, Icks A, et al. Incidence of blindness in relation to diabetes: a population-based study. Diabetes-Care 1997;20:1147–53. PubMed

Gatling W, Howie AJ, Hill RD. An optical practice based diabetic eye screening programme. Diabet Med 1995;12:531–6. PubMed

Chew EY, Mills JL, Metzger BE, et al. National Institute of Child Health and Human Development. Diabetes in early pregnancy study. Metabolic control and progression of retinopathy. Diabetic care 1995;18:631–7. PubMed

Klein R, Klein BEK, Moss SE. The Wisconsin epidemiological study on diabetic retinopathy. XIV—10 year incidence and progression of diabetic retinopathy. Arch ophthalmol 1994;112:1217–28. PubMed

Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med 1991;8:263–7. PubMed

Rohan TE, Frost CD, Wald NJ. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ 1989;299:1198–201. PubMed PMC

Nielsen NV. The prevalence and causes of impaired vision in diabetics. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol (Copenh) 1982;60:677–91. PubMed

Johnson GJ. Rapid survey methodologies for glaucoma. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness, 2001:181–8.

Klein BEK, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1999;99:1499–1504. PubMed

Johnson G. The glaucomas. In: Johnson GJ, Minassian DC, Weale R, eds. The epidemiology of eye disease. 1st ed. London: Chapman and Hall 1998:159–80.

Quigley H. The number of persons with glaucoma worldwide. Br J Ophthalmol 1996;80:389–393. PubMed PMC

Wilson MR, Martone JF. Epidemiology of open angle glaucoma. In: Ritch R, Shields B, Krupin T, eds. The glaucomas. 2nd ed. St Louis: Mosby, 1996:753–68.

Gramer E, Tausch M. The risk of the glaucomatous patient. Curr Opin Ophthalmol 1995;6:78–88. PubMed

Wormald RP. Rauf A. Glaucoma screening. J Med Screen 1995;2:109–14. PubMed

Coffey M, Reidy A, Wormald R, et al. Prevalence of glaucoma in the West of Ireland. Br J Ophthalmol 1993;77:17–21. PubMed PMC

Congdon N, Wang F, Tielsch JM. Issues in the epidemiology and population based screening of primary angle closure glaucoma. Surv Ophthalmol 1992;36:411–23. PubMed

Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Organ 1987;65:477–83. PubMed PMC

Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma, and diabetic retinopathy. Am J Epidemiol 1983;118:206–12. PubMed

Ng YK, Fielder AR, Shaw DE, et al. Epidemiology of retinopathy of prematurity. Lancet 1988;2:1235–8. PubMed

Billson F. Prevention of blindness in children—human resource development. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness, 2001:75–82.

Gilbert C, Foster A. Childhood blindness in the context of Vision 2020—the right to sight. Bull World Health Organ 2001;79:227–32. PubMed PMC

Gilbert C. Childhood blindness in the context of the global initiative. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness, 2001:71–4.

Rahi JS, Gilbert CE, Foster A, et al. Measuring the burden of childhood blindness. Br J Ophthalmol 1999;83:387–8. PubMed PMC

World Health Organization. Prevention of Childhood Blindness. Geneva: WHO, 1992.

Willshaw HE. Ophthalmic services for children. Br J Ophthalmol 1996;80:388. PubMed PMC

Kraut JA, McCabe P. The problem of low vision. Definition and common problems. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. 1st ed. Philadelphia: WB Saunders, 1994.

McCabe P. Vision rehabilitation programme overview. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. 1st ed. Philadelphia: WB Saunders, 1994.

Thompson JR, Woodruff G, Hiscox FA, et al. The incidence and prevalence of amblyopia detected in childhood. Public Health 1991;105:455–62. PubMed

Duldulao EC, ed. Vision for the future. International Council of Ophthalmology, 2001.

Foster A. Vision 2020—the right to sight. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness, 2001:431–5.

Thylefors B. Vision 2020: the right to sight global initiative for the elimination of avoidable blindness. In: Pararajasegaram R, Rao GN, eds. World blindness and its prevention. Proceedings of the Sixth IAPB General Assembly. Hyderabad: International Agency for the Prevention of Blindness 2001:25–33.

Thylefors B. A mission for vision. Lancet 2000;354:SIV44. PubMed

Thylefors B. The WHO programme for the prevention of blindness and cataract in developing countries. Doc Ophthalmol 1992;81:339–44. PubMed

Johns A. The International Agency for the Prevention of Blindness and non-governmental organizations: an effective network. Int Ophthalmol 1990;14:227–30. PubMed